Cardiovascular disease and chronic kidney disease: Insights and an update
Open Access
- 31 August 2004
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 148 (2) , 230-242
- https://doi.org/10.1016/j.ahj.2004.04.011
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventionsAmerican Heart Journal, 2003
- Sustained-Release Diltiazem Reduces Myocardial Ischemic Episodes in End-Stage Renal DiseaseJournal of the American Society of Nephrology, 2003
- Recurrence of Left Ventricular Hypertrophy Following Cessation of Erythropoietin TherapyArtificial Organs, 2002
- Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis StudyKidney International, 2000
- Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic statusJournal of the American College of Cardiology, 2000
- Oxidized Monocyte-Derived Macrophages in Aortic Atherosclerotic Lesion from Apolipoprotein E-Deficient Mice and from Human Carotid Artery Contain Lipid Peroxides and OxysterolsBiochemical and Biophysical Research Communications, 2000
- Long-term outcome of dialysis patients in the United States with coronary revascularization proceduresKidney International, 1999
- Patient mortality and survival. United States Renal Data SystemAmerican Journal of Kidney Diseases, 1998
- Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial)The American Journal of Cardiology, 1990
- DOES ASPIRIN PRECIPITATE MAJOR GASTROINTESTINAL BLEEDING IN PATIENTS ON HÆMODIALYSIS?The Lancet, 1977